Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Cureus|September 9, 2020
COVID-19 Presenting as Severe Rhabdomyolysis With Normal Renal FunctionAkshay Shanbhag, Pritika S Manaktala, Hira Rizvi, et al.
Carcinogenesis|January 4, 2015
Antitumor effects of hyaluronan inhibition in desmoid tumorsAlexandra Briggs, Laura Rosenberg, Justin D Buie, et al.
Cancer Discovery|May 14, 2020
Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung CancersJia Luo, Hira Rizvi, Jacklynn V Egger, et al.
Gynecologic Oncology Reports|June 20, 2018
Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumorsMadhuri Martin, Joshua K Sabari, Gulisa Turashvili, et al.
The Journal of Surgical Research|January 4, 2011
Immunohistochemical and molecular analysis of tyrosine kinase activity in desmoid tumorsNancy L Cho, Adelaide M Carothers, Hira Rizvi, et al.
Biochemical and Biophysical Research Communications|February 4, 2014
Lack of anti-tumor activity with the β-catenin expression inhibitor EZN-3892 in the C57BL/6J Min/+ model of intestinal carcinogenesisRian M Hasson, Alexandra Briggs, Hira Rizvi, et al.
Cancer Research|November 19, 2011
Mesenchymal stromal cell mutations and wound healing contribute to the etiology of desmoid tumorsAdelaide M Carothers, Hira Rizvi, Rian M Hasson, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2021
Intra- and inter-reader agreement of iRECIST and RECIST 1.1 criteria for the assessment of tumor response in patients receiving checkpoint inhibitor immunotherapy for lung cancerSandra Huicochea Castellanos, Andrew Pagano, Andrew J Plodkowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Safety of Programmed Death-1 Pathway Inhibitors Among Patients With Non-Small-Cell Lung Cancer and Preexisting Autoimmune DisordersGiulia C Leonardi, Justin F Gainor, Mehmet Altan, et al.
The Lancet. Digital Health|August 1, 2021
The use of a next-generation sequencing-derived machine-learning risk-prediction model (OncoCast-MPM) for malignant pleural mesothelioma: a retrospective studyMarjorie G Zauderer, Axel Martin, Jacklynn Egger, et al.
Pageof 6